跳至主要内容
临床试验/EUCTR2014-002674-36-NL
EUCTR2014-002674-36-NL进行中(未招募)1 期

DOES ARGININE ENHANCE GALACTOSE OXIDATIVE CAPACITY IN CLASSIC GALACTOSEMIA? A PILOT STUDY

未提供0 个研究点目标入组 5 人开始时间: 2017年9月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • 1.Classic galactosemia patient homozygous for the p.Q188R mutation, diagnosed by
  • GALT enzyme activity assay and GALT gene mutation analysis
  • 2.Eighteen years of age or older
  • 3.Capable of giving informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • 1.Urea cycle disorders (assessed by post prandial amino acid profile in blood)
  • 2.Increased level of plasma uric acid
  • 3.Patients experiencing acute illness of classic galactosemia
  • 4.Pregnant women (or considering getting pregnant) or breastfeeding women

研究者

发起方
未提供

相似试验

Arginine as medication to improve outcome in... | 临床试验